We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

The Advantages of Machine Learning and Artificial Intelligence in the Drug Discovery Process

Video   Nov 20, 2018

 

Dr Ola Engkvist, AstraZeneca, explains how the drug discovery process benefits from artificial intelligence and machine learning.


 
More Information
 
 
 

Recommended Videos

Ulcerative Colitis: Fresh Approaches to Taming Inflammation

Video

This animation explores how insights into the immunobiology of ulcerative colitis are helping researchers to develop innovative treatments.

WATCH NOW

How Deep Learning Architectures Have Improved Chemical Reaction Prediction

Video

Dr Ola Engkvist, AstraZeneca, explains how deep learning architectures improve chemical reaction prediction.

WATCH NOW

Applying Deep Learning Architectures to de novo Molecular Drug Design

Video

Dr Ola Engkvist, AstraZeneca, outlines how deep learning architectures are being applied to drug discovery.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Drug Discovery Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE